Clinical trials
Diabetes Mellitus in Pregnancy clinical trials
Below are recruiting diabetes mellitus in pregnancy clinical trials, each written for real people, not researchers. We’re tracking 314 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07173062Recruiting
Algae supplement for heart health and gut bacteria
This study tests whether a supplement made from algae can help improve markers of heart health and affect the bacteria in your gut. It is for people age 50 and older who already have a condition like heart disease, kidney disease, or diabetes.
PortoAges 50 years+ - NCT07309094Recruiting
Effects of a diabetes drug on fat tissue in kidney disease
This trial tests whether a GLP-1 receptor agonist (a type of diabetes medication) can improve fat tissue health in people with chronic kidney disease who also have type 2 diabetes, cardiovascular disease, or obesity. It may help protect your kidneys and overall health.
Valencia, ValenciaAges 18–90 - NCT07320495Recruiting
Automated insulin delivery for type 1 diabetes
This trial tests a new automated insulin delivery system (APGO algorithm) to see how well it controls blood sugar and if it's safe. It may help people with type 1 diabetes manage their condition more easily.
PragueAges 18 years+ - NCT07375680Recruiting
Blood sugar and stomach emptying study before surgery
This study uses a simple stomach ultrasound before surgery to see how fast your stomach empties. It compares that to your HbA1c (a measure of average blood sugar) to better understand how diabetes might affect digestion during anesthesia.
Kütahya, KütahyaAges 18–70 - NCT07391319RecruitingPhase 3
Testing a new treatment for diabetic foot ulcers
This trial tests a new treatment for foot ulcers caused by poor blood flow and diabetes. It compares the new treatment to a placebo (an inactive substance) to see if it helps ulcers heal better.
MoscowAges 18 years+ - NCT01999374Recruiting
Long-term follow-up for people with transplanted islet cells
This study checks how well transplanted islet cells are working over time and monitors long-term safety. If you previously received an islet transplant and are still using medicine to prevent rejection, you may be followed again.
Miami, FloridaAges 18–65 - NCT01999361Recruiting
Prevent new immune reaction after islet transplant failure
This study looks at ways to prevent the body from developing a new harmful immune reaction after an islet transplant no longer works. It may help people who have already lost a transplanted islet graft from getting harder-to-treat immune responses later.
Miami, FloridaAges 18–70 - NCT01957696Enrolling by invitation
Study of pancreas (and sometimes kidney) transplant outcomes
This study looks at people who receive a pancreas transplant, with or without a same-time kidney transplant, and follows them to understand their results. It may help improve how transplant teams choose patients and manage care after surgery.
OsloAges 18–65 - NCT07401992RecruitingPhase 4
Semaglutide for psoriasis and weight management
This trial tests if semaglutide, a diabetes and weight-loss medication, can improve psoriasis symptoms and reduce inflammation. It may be an option for people with both psoriasis and overweight or obesity, with or without diabetes.
Monterrey, N.L.Ages 18 years+ - NCT07414277Recruiting
CGM for insulin-treated type 2 diabetes after hospital discharge
This study tests whether using a continuous glucose monitor (CGM) can help people with type 2 diabetes who need insulin after leaving the hospital. It aims to improve blood sugar control during this transition period.
ShanghaiAges 18–80 - NCT07447362Recruiting
Managing heart health risks in adults
This study checks if a program to manage heart health risks works better than usual care. If you have a risk factor like high blood pressure, diabetes, or smoking, you may qualify.
Santiago, Santiago MetropolitanAges 18 years+ - NCT07448805Recruiting
Accuracy and safety of a glucose monitor in the ICU
This trial tests a continuous glucose monitoring system (Syai Tag) in the intensive care unit (ICU). It aims to see how well it measures blood sugar levels safely compared to standard methods.
MariborAges 18 years+ - NCT07489482RecruitingPhase 1
Comparing SHR-3167 injection bioavailability and safety
This trial tests how a new medicine (SHR-3167) is absorbed by the body and checks for side effects. Healthy volunteers ages 18-55 can join to help researchers understand how this drug works.
Changsha, HunanAges 18–55 - NCT07518407Recruiting
Nutrition Education and Diet Guidance While Using GLP-1 Medication
This study teaches adults on GLP-1 medication (like Ozempic or Wegovy) how to eat better and lose weight using a smartphone app. Researchers want to see if personalized nutrition advice helps you get better results from your medication.
Columbia, South CarolinaAges 18–65 - NCT07540754RecruitingPhase 1
How Your Liver Processes a New Injection Medicine
This study tests how your body processes a new medicine called HRS9531 when injected. Researchers want to understand how liver function affects the medicine's breakdown, which helps them determine safe doses for future patients.
Zhengzhou, HenanAges 18–65 - NCT07588438RecruitingPhase 4
Tirzepatide effectiveness and safety for diabetes and weight loss in Paraguay
This study tests how well and safely tirzepatide (a new injectable medication) works in real-world conditions for people with type 2 diabetes or obesity in Paraguay. The medication helps lower blood sugar and reduce weight.
AsunciónAges 18–70 - NCT07636395Recruiting
How obesity medication affects your eating habits
This study tracks how your eating behavior changes when you take obesity medication. Researchers want to understand what happens to your appetite and food choices before, during, and after treatment to help improve how these medications work.
DublinAges 16–80 - NCT07488767Enrolling by invitation
Food order study for diabetes with food insecurity
This study looks at whether changing the order you eat your food (like vegetables first, then carbs) can help people with prediabetes or diabetes who also experience food insecurity. It aims to find simple, low-cost ways to improve blood sugar control.
New York, New YorkAges 18–75 - NCT07209527Enrolling by invitationEarly Phase 1
Truway diagnostic tools in primary care
This trial tests new diagnostic tools that doctors can use in primary care. Researchers want to see if these tools help find the right diagnosis faster and more accurately.
New York, New YorkAges Any age - NCT06801886Enrolling by invitationPhase 3
Silymarin for better kidney transplant success
This trial tests if adding silymarin (a milk thistle extract) to standard anti-rejection medicines helps protect the new kidney from damage. It may improve how well the transplanted kidney works over time.
MartinAges Any age - NCT06519448Enrolling by invitation
Testing a pill for non-alcoholic fatty liver disease
This trial tests a diabetes drug called empagliflozin to see if it can reduce fat and inflammation in the liver in people with a specific type of fatty liver disease called NASH. It may help if you have NASH and either have type 2 diabetes or don't have it.
PragueAges 18–75 - NCT05659147Enrolling by invitationPhase 4
MRI study of pancreas function in children with pancreatic issues
This study uses a special pancreas MRI to see how well the pancreas works and how pancreas disease changes over time. It also compares MRI findings in children with different pancreas conditions, including suspected pancreatic insufficiency and episodes of pancreatitis.
Cincinnati, OhioAges 5–21 - NCT04585204Recruiting
Tests which sugar drink best detects gestational diabetes
This study compares two different sugar drinks during pregnancy to see which one better identifies gestational diabetes that may need medical treatment. It may help your care team choose the most useful test for you and similar pregnancies.
AnkaraAges 18–45 - NCT05835596Enrolling by invitation
App-based support to protect heart health after pregnancy
This trial tests whether a smartphone app (“MumCare”) can help improve or support cardiovascular (heart and blood vessel) health in people after certain pregnancy complications. It’s for new or recent moms who had pregnancy-related high blood pressure and/or gestational diabetes.
Oslo, OsloAges 18–50
Hear when a new Diabetes Mellitus in Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes mellitus in pregnancy?
- Yes. Clin2 currently lists 314 recruiting diabetes mellitus in pregnancy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes mellitus in pregnancy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes mellitus in pregnancy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.